TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia

东南亚中低收入国家结核病/耐多药结核病研究能力建设

基本信息

  • 批准号:
    9207135
  • 负责人:
  • 金额:
    $ 21.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-05-01 至 2020-01-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This training program's goal is to strengthen TB research capacity, especially human resources of TB research at LMIC collaborating centers, namely the National Tuberculosis Program of Myanmar; Department of Medical Research Upper and Lower Myanmar; Bureau of Tuberculosis of Thailand (BTB); and University of North Sumatra (USU), Andalas University of West Sumatra (UNAND), and Syiah Kuala University of Aceh (SKU), Indonesia. The training program will focus on multidrug-resistant TB (MDR-TB), which is a major problem in the Southeast Asia region. This will eventually lead to better future control of TB and other global infectious diseases. The program objectives are to train researchers from collaborating centers (LMIC-Indonesia, Myanmar and Thailand) to achieve MSc/PhD in Epidemiology at Prince of Songkla University, with a special focus on MDR-TB research, and to provide short course training in TB Epidemiology/Biostatistics and TB laboratory science to various researchers of the collaborating centers. The long-term training to produce 6 PhD and 6 MSc graduates will be based at the Epidemiology Unit, Prince of Songkla University (EPI-PSU), experienced in producing over 130 epidemiological Doctoral and Master researchers to Asia and Africa. This is incorporated with supplementary short-term training at the Departments of Microbiology at Siriraj Hospital and Faculty of Science of Mahidol University (MICRO-MU), and at a center of excellence for TB research and TB field observation at Zonal TB Center 12 Yala (ZTC12). In addition, short-term training will be conducted at EPI-PSU to train 19 researchers and at MICRO-MU to train 14 researchers. All trainees will be initially selected by the target institutes from Myanmar, Indonesia and Thailand, and reviewed by a Training Advisory Group (TAG). The long-term training curriculum consists of one year coursework (shared by PhD and MSc programs) emphasizing Epidemiology/Biostatistics, Research Methodology, Responsible Conduct of Research, and data analysis. This is followed by data collection for research thesis related to MDR-TB (1 year for PhD and 6 months for MSc) at home institutes of the trainees. Finally, another year for the PhD and 6 months for the MSc trainees will be spent on data analysis and report writing at EPI-PSU. Apart from technical quality, arrangement has been made to ensure enough diversity of trainees, maximum retention and continuation of research career development after the training has been completed.
 描述(申请人提供):该培训项目的目标是加强结核病研究能力,特别是LMIC合作中心的结核病研究人力资源,即缅甸国家结核病计划;上缅甸和下缅甸医学研究部;泰国结核病局(BTB);以及印度尼西亚北苏门答腊大学、西苏门答腊安达拉斯大学和亚齐西亚瓜拉大学。培训计划将侧重于耐多药结核病(MDR-TB),这是东南亚地区的一个主要问题。这将最终导致未来更好地控制结核病和其他全球传染病。该计划的目标是培训合作中心(LMIC-印度尼西亚,缅甸和泰国)的研究人员在宋卡王子大学获得流行病学硕士/博士学位,特别关注耐多药结核病研究,并为合作中心的各种研究人员提供结核病流行病学/生物统计学和结核病实验室科学的短期培训。培养6名博士和6名硕士毕业生的长期培训将在宋卡王子大学(EPI-PSU)流行病学单位进行,该单位在亚洲和非洲培养了130多名流行病学博士和硕士研究人员。这与在马希窦大学(MICRO-MU)微生物学系和在Yala区结核病中心12(ZTC 12)的结核病研究和结核病现场观察卓越中心的补充短期培训相结合。此外,还将在EPI-PSU进行短期培训,培训19名研究人员,并在MICRO-MU培训14名研究人员。所有受训人员将由缅甸、印度尼西亚和泰国的目标机构初步挑选,并由培训咨询小组审查。长期培训课程包括为期一年的课程(由博士和硕士课程共享),强调流行病学/生物统计学,研究方法,负责任的研究行为和数据分析。然后在受训人员的国内研究所收集与耐多药结核病有关的研究论文的数据(博士1年,硕士6个月)。最后,另外一年的博士和6个月的硕士学员将在EPI-PSU进行数据分析和报告撰写。除技术质素外,我们亦已作出安排,以确保学员足够多元化、最大限度地保留人才,以及在培训完成后继续进行研究事业发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Angkana Chaiprasert其他文献

Angkana Chaiprasert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Angkana Chaiprasert', 18)}}的其他基金

TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: End-of-Fiscal-Year Supplement
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段:财年末补充文件
  • 批准号:
    10877205
  • 财政年份:
    2023
  • 资助金额:
    $ 21.59万
  • 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: Promotion of Diversity, Equity and Inclusion (DEI)
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段:促进多样性、公平和包容性 (DEI)
  • 批准号:
    10873650
  • 财政年份:
    2023
  • 资助金额:
    $ 21.59万
  • 项目类别:
TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia
东南亚中低收入国家结核病/耐多药结核病研究能力建设
  • 批准号:
    8890980
  • 财政年份:
    2015
  • 资助金额:
    $ 21.59万
  • 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段
  • 批准号:
    10238181
  • 财政年份:
    2015
  • 资助金额:
    $ 21.59万
  • 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段
  • 批准号:
    10393653
  • 财政年份:
    2015
  • 资助金额:
    $ 21.59万
  • 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段
  • 批准号:
    10577817
  • 财政年份:
    2015
  • 资助金额:
    $ 21.59万
  • 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
  • 批准号:
    7934826
  • 财政年份:
    2010
  • 资助金额:
    $ 21.59万
  • 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
  • 批准号:
    8111903
  • 财政年份:
    2010
  • 资助金额:
    $ 21.59万
  • 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
  • 批准号:
    8298473
  • 财政年份:
    2010
  • 资助金额:
    $ 21.59万
  • 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
  • 批准号:
    8502235
  • 财政年份:
    2010
  • 资助金额:
    $ 21.59万
  • 项目类别:

相似国自然基金

烟粉虱AsiaⅡ7和MED隐种对CLCuMuV的自噬作用及其分子机制
  • 批准号:
    32001973
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
烟粉虱AsiaⅡ7和MED隐种中肠在传播双生病毒差异性中的分子机制
  • 批准号:
    2020A151501098
  • 批准年份:
    2020
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
Asia Ⅱ7和MEAM1烟粉虱传播木尔坦棉花曲叶病毒能力差异的分子机理
  • 批准号:
    31871937
  • 批准年份:
    2018
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Asia1型口蹄疫病毒RGD基序突变株识别受体的鉴定和比较
  • 批准号:
    31302118
  • 批准年份:
    2013
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
紫云英二磷酸核苷磷酸酯酶AsIA257在共生固氮过程中的功能研究
  • 批准号:
    31000115
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
口蹄疫Asia-I型病毒VP1和3D基因在山羊痘病毒共表达关系的研究
  • 批准号:
    30760181
  • 批准年份:
    2007
  • 资助金额:
    17.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

An Alternative Mode of Student Well-Being or Unhappy Schools? Exploring Interdependence in Education across East and Southeast Asia, Building Evidence to Impact the Post-SDG 2030 Global Policy Agenda
学生福祉的替代模式还是不快乐的学校?
  • 批准号:
    23K25636
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Paths to primacy: How rising powers win domination in Asia, 1500-present
通往霸主之路:崛起中的大国如何赢得亚洲统治地位(1500 年以来)
  • 批准号:
    FT230100547
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    ARC Future Fellowships
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
  • 批准号:
    24K13490
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ELF COIL with partners from Southeast Asia and Its Impact on Study Abroad Intent
ELF COIL与东南亚合作伙伴及其对留学意向的影响
  • 批准号:
    24K16145
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Re-evaluating Minority Shareholding in Competition Law Against the Background of Horizontal Shareholding by Investors: Lessons Drawn From Fintech and E-Commerce Startups in Asia
投资者横向持股背景下重新评估竞争法中的少数股权:亚洲金融科技和电子商务初创企业的经验教训
  • 批准号:
    23K20574
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Writing Scottish Asia: Evangelism, Emigration, and Estrangement, 1839 - 1910
写作苏格兰亚洲:传福音、移民和疏远,1839 年 - 1910 年
  • 批准号:
    24K03743
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
From Crisis to Resilience: The Social - Ecological Systems (SES) Approach to Tourism Recovery in East Asia
从危机到恢复力:东亚旅游业复苏的社会生态系统(SES)方法
  • 批准号:
    23K25113
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Cross-border energy planning for just transition in Southeast Asia
东南亚公正转型的跨境能源规划
  • 批准号:
    24K20970
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Modernism's East Asia: Semi-Asiatic Literature and Global Modernity
现代主义的东亚:半亚洲文学与全球现代性
  • 批准号:
    DE240101070
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Discovery Early Career Researcher Award
Peri-anesthetic morbidity in children in Asia (PEACH in Asia): A prospective multinational multicenter study to investigate epidemiology of severe critical events in pediatric anesthesia in Asia
亚洲儿童围麻醉期发病率(PEACH in Asia):一项前瞻性多中心研究,旨在调查亚洲儿科麻醉中严重危急事件的流行病学
  • 批准号:
    24K13535
  • 财政年份:
    2024
  • 资助金额:
    $ 21.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了